Search clinical trials for: Ixazomib
Total 163 results
-
Mayo ClinicTakedaCompleted
-
Millennium Pharmaceuticals, Inc.Completed
-
Millennium Pharmaceuticals, Inc.CompletedFollicular LymphomaUnited States, United Kingdom, Belgium, Canada
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Advanced Solid TumorsUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors | Hematologic MalignanciesUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.Completed
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaActive, not recruitingMultiple Myeloma | Autologous Stem Cell TransplantUnited States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
-
University Hospital, CaenRecruiting
-
RenJi HospitalRecruitingOverall Survival | Progression Free Survival | MaintenanceChina
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
TakedaTerminatedLupus NephritisUnited States, France, United Kingdom, Germany, Spain, Russian Federation, Italy
-
Stanford UniversitySpringWorks Therapeutics, Inc.Recruiting
-
Millennium Pharmaceuticals, Inc.Completed
-
Ho Sup LeeTakedaRecruitingMantle Cell LymphomaKorea, Republic of
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Shaoxing Second Hospital; Huizhou Municipal Central... and other collaboratorsRecruiting
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium...Active, not recruitingMantle Cell LymphomaUnited States
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and Refractory Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Advanced Solid TumorsUnited States, Canada
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyTerminated
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, T-CellUnited States
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium
-
Dr. Grace ParragaAstraZenecaActive, not recruiting
-
TakedaCompletedMultiple MyelomaFrance, Spain, United States, Taiwan, Korea, Republic of, Israel, Australia, Czechia, Hungary, Canada, Japan, Portugal, Singapore, United Kingdom, Italy, Sweden, Poland, Germany, China, Denmark, Greece, Thailand, Serbia, Turkey, Colombia, Russian Federation and more
-
Emory UniversityTakedaCompleted
-
Mehdi HamadaniCompletedAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnPrecursor Cell Lymphoblastic Leukemia-lymphomaSpain, United States
-
Matthew InghamTakeda; Karyopharm Therapeutics IncWithdrawnSarcoma | Ewing Sarcoma | Liposarcoma | Alveolar Soft Part Sarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
H Scott BoswellTakedaTerminatedAML | AML, AdultUnited States
-
PfizerCompletedAdvanced Solid TumorsUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Recruiting
-
Northside Hospital, Inc.Millennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | Acute Leukemia | Myelodysplastic Syndrome | Lymphomas | Chronic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Hellenic Society of HematologyTakeda; Janssen Pharmaceutica NVUnknown
-
Taichung Veterans General HospitalChang Gung Memorial Hospital; National Cheng-Kung University Hospital; E-DA Hospital and other collaboratorsRecruiting
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Nonhematologic MalignanciesUnited States
-
Peking Union Medical College HospitalThe First Affiliated Hospital of Anhui Medical University; Peking University... and other collaboratorsRecruiting